Telcare, a Bethesda, MD-based digital health company, raised $32.5m in Series C funding.
The round was led by Norwest Venture Partners (NVP) with participation from Mosaic Health Solutions, and existing investors Sequoia Capital and Qualcomm. In conjunction with the funding, NVP Partner Casper de Clerq will join Telcare’s board.
The company intends to use the funds to broaden its impact in diabetes and expand the platform to related chronic conditions.
Led by Andrew Flanagan, CEO, Telcare provides a cellular-enabled blood glucose meter, diabetes mobile application, and comprehensive HIPAA compliant cloud platform. The Telserve cloud proactively delivers messages and reminders, along with personalized education, and keeps the patient’s doctor in the loop with updates and diagnostic data capture.